QIX Dividenden Europa
|
16 640,35
|
1,29
|
0,01 %
|
Analysen zu QIX Dividenden Europa-Werten
| 30.10.25 | GSK Halten | DZ BANK | |
| 30.10.25 | TotalEnergies Buy | UBS AG | |
| 30.10.25 | GSK Hold | Deutsche Bank AG | |
| 30.10.25 | Mercedes-Benz Group Neutral | UBS AG | |
| 30.10.25 | GSK Neutral | UBS AG | |
| 30.10.25 | Mercedes-Benz Group Buy | Deutsche Bank AG | |
| 30.10.25 | TotalEnergies Hold | Jefferies & Company Inc. | |
| 30.10.25 | TotalEnergies Outperform | RBC Capital Markets | |
| 30.10.25 | Mercedes-Benz Group Market-Perform | Bernstein Research | |
| 30.10.25 | Mercedes-Benz Group Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.10.25 | Mercedes-Benz Group Hold | Jefferies & Company Inc. | |
| 30.10.25 | Mercedes-Benz Group Overweight | JP Morgan Chase & Co. | |
| 29.10.25 | Iberdrola Hold | Deutsche Bank AG | |
| 29.10.25 | GSK Outperform | Bernstein Research | |
| 29.10.25 | Iberdrola Buy | UBS AG | |
| 29.10.25 | GSK Neutral | UBS AG | |
| 29.10.25 | GSK Buy | Jefferies & Company Inc. | |
| 29.10.25 | Mercedes-Benz Group Neutral | UBS AG | |
| 29.10.25 | Mercedes-Benz Group Buy | Warburg Research | |
| 29.10.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 29.10.25 | Mercedes-Benz Group Hold | Jefferies & Company Inc. | |
| 29.10.25 | Mercedes-Benz Group Market-Perform | Bernstein Research | |
| 29.10.25 | Mercedes-Benz Group Overweight | JP Morgan Chase & Co. | |
| 29.10.25 | Mercedes-Benz Group Sector Perform | RBC Capital Markets | |
| 28.10.25 | DHL Group Overweight | JP Morgan Chase & Co. | |
| 28.10.25 | Iberdrola Verkaufen | DZ BANK | |
| 28.10.25 | TotalEnergies Outperform | RBC Capital Markets | |
| 28.10.25 | Iberdrola Buy | UBS AG | |
| 28.10.25 | Iberdrola Buy | Jefferies & Company Inc. | |
| 28.10.25 | Iberdrola Sector Perform | RBC Capital Markets | |
| 28.10.25 | Iberdrola Neutral | JP Morgan Chase & Co. | |
| 27.10.25 | Roche Outperform | Bernstein Research | |
| 27.10.25 | GSK Hold | Deutsche Bank AG | |
| 27.10.25 | VINCI Overweight | Barclays Capital | |
| 27.10.25 | Swiss Re Underweight | Barclays Capital | |
| 27.10.25 | Roche Underperform | Jefferies & Company Inc. | |
| 27.10.25 | Hannover Rück Underweight | Barclays Capital | |
| 27.10.25 | GSK Buy | Jefferies & Company Inc. | |
| 27.10.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 27.10.25 | Hennes & Mauritz AB Underweight | JP Morgan Chase & Co. |